AtorvastatinImmune-mediated necrotising myopathy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1865卷 / 1期

关键词：

D O I：

10.1007/s40278-021-99376-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：88 / 88

相关论文

共 50 条

[31] SimvastatinImmune-mediated necrotising myopathy: case report
Reactions Weekly, 2020, 1817 (1) : 289 - 289
[32] TozinameranImmune-mediated necrotising myopathy: case report
Reactions Weekly, 2022, 1905 (1) : 479 - 479
[33] LovastatinImmune-mediated necrotising myopathy: case report
Reactions Weekly, 2021, 1886 (1) : 253 - 253
[34] SimvastatinImmune-mediated necrotising myopathy: case report
Reactions Weekly, 2018, 1689 (1) : 174 - 174
[35] RosuvastatinImmune-mediated-necrotising-myopathy: case report
Reactions Weekly, 2022, 1919 (1) : 539 - 539
[36] AtorvastatinImmune mediaed necrotizing myopathy: case report
Reactions Weekly, 2016, 1608 (1) : 44 - 44
[37] AtorvastatinImmune‐mediated necrotizing myopathy
Reactions Weekly, 2024, 2000 (1) : 62 - 62
[38] AdalimumabFulminant immune-mediated necrotising myopathy: case report
Reactions Weekly, 2020, 1835 (1) : 13 - 13
[39] Atorvastatin/evolocumabImmune-mediated necrotising myopathy: case report
Reactions Weekly, 2025, 2051 (1) : 47 - 47
[40] AtorvastatinRhabdomyolysis and immune-mediated necrotising myopathy: case report
Reactions Weekly, 2024, 2035 (1) : 88 - 88

← 1 2 3 4 5 →